| abstract |
Pyrimidinone compounds having the formula (I), their preparation and use are disclosed. The compound is an inhibitor of HMG-CoA reductase and thus has antiviral activity, treats cardiovascular and cerebrovascular diseases, senile dementia, diabetes mellitus, osteoporosis and tumors and enhances immune function in patients It is particularly useful for treating and preventing diseases associated with hyperlipidemia. |